TY - JOUR
T1 - Toward a personalized therapy for panic disorder
T2 - preliminary considerations from a work in progress
AU - Caldirola, Daniels
AU - Perna, Giampaolo
N1 - Funding Information:
The authors would like to thank Alice Riva, MSc, and Erika Sangiorgio, PsyD, for their assistance with the preparation of the manuscript. The authors would also like to thank Enago for the English language review.
Publisher Copyright:
© 2019 Caldirola and Perna.
PY - 2019
Y1 - 2019
N2 - Although several treatment options for panic disorder (PD) are available, the best intervention for each individual patient remains uncertain and the use of a more personalized therapeutic approach in PD is required. In clinical practice, clinicians combine general scientific information and personal experience in the decision-making process to choose a tailored treatment for each patient. In this sense, clinicians already use a somehow personalized medicine strategy. However, the influence of their interpretative personal models may lead to bias related to personal convictions, not sufficiently grounded on scientific evidence. Hence, an effort to give some advice based on the science of personalized medicine could have positive effects on clinicians' decisions. Based on a narrative review of meta-analyses, systematic reviews, and experimental studies, we proposed a first-step attempt of evidence-based personalized therapy for PD. We focused on some phenomenological profiles, encompassing symptoms during/outside panic attacks, related patterns of physiological functions, and some aspects of physical health, which might be worth considering when developing treatment plans for patients with PD. We considered respiratory, cardiac, vestibular, and derealization/depersonalization profiles, with related implications for treatment. Given the extensiveness of the topic, we considered only medications and some somatic interventions. Our proposal should be considered neither exhaustive nor conclusive, as it is meant as a very preliminary step toward a future, robust evidence-based personalized therapy for PD. Clearly much more work is needed to achieve this goal, and recent technological advances, such as wearable devices, big data platforms, and the application of machine learning techniques, may help obtain reliable findings. We believe that combining the efforts of different research groups in this work in progress can lead to largely shared conclusions in the near future.
AB - Although several treatment options for panic disorder (PD) are available, the best intervention for each individual patient remains uncertain and the use of a more personalized therapeutic approach in PD is required. In clinical practice, clinicians combine general scientific information and personal experience in the decision-making process to choose a tailored treatment for each patient. In this sense, clinicians already use a somehow personalized medicine strategy. However, the influence of their interpretative personal models may lead to bias related to personal convictions, not sufficiently grounded on scientific evidence. Hence, an effort to give some advice based on the science of personalized medicine could have positive effects on clinicians' decisions. Based on a narrative review of meta-analyses, systematic reviews, and experimental studies, we proposed a first-step attempt of evidence-based personalized therapy for PD. We focused on some phenomenological profiles, encompassing symptoms during/outside panic attacks, related patterns of physiological functions, and some aspects of physical health, which might be worth considering when developing treatment plans for patients with PD. We considered respiratory, cardiac, vestibular, and derealization/depersonalization profiles, with related implications for treatment. Given the extensiveness of the topic, we considered only medications and some somatic interventions. Our proposal should be considered neither exhaustive nor conclusive, as it is meant as a very preliminary step toward a future, robust evidence-based personalized therapy for PD. Clearly much more work is needed to achieve this goal, and recent technological advances, such as wearable devices, big data platforms, and the application of machine learning techniques, may help obtain reliable findings. We believe that combining the efforts of different research groups in this work in progress can lead to largely shared conclusions in the near future.
KW - pharmacotherapy
KW - somatic
KW - evidence-based
KW - panic
KW - HEART-RATE-VARIABILITY
KW - 35-PERCENT CO2 HYPERREACTIVITY
KW - SEROTONIN REUPTAKE INHIBITORS
KW - MEAN PLATELET VOLUME
KW - RESPIRATORY SUBTYPE
KW - AEROBIC EXERCISE
KW - VESTIBULAR DYSFUNCTION
KW - ANXIETY DISORDERS
KW - PHOSPHATE LEVELS
KW - PAROXETINE
U2 - 10.2147/NDT.S174433
DO - 10.2147/NDT.S174433
M3 - (Systematic) Review article
C2 - 31371969
SN - 1176-6328
VL - 15
SP - 1957
EP - 1970
JO - Neuropsychiatric Disease and Treatment
JF - Neuropsychiatric Disease and Treatment
ER -